DK0790245T3 - Substituerede thiophenylalkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf - Google Patents

Substituerede thiophenylalkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf

Info

Publication number
DK0790245T3
DK0790245T3 DK97101597T DK97101597T DK0790245T3 DK 0790245 T3 DK0790245 T3 DK 0790245T3 DK 97101597 T DK97101597 T DK 97101597T DK 97101597 T DK97101597 T DK 97101597T DK 0790245 T3 DK0790245 T3 DK 0790245T3
Authority
DK
Denmark
Prior art keywords
drug
diagnostic
preparation
carboxylic acid
substituted thiophenylalkenyl
Prior art date
Application number
DK97101597T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Dr Scholz
Jan-Robert Dr Schwark
Hans Jochen Dr Lang
Heinz-Werner Dr Kleemann
Andreas Dr Weichert
Udo Dr Albus
Joachim Dr Brendel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0790245T3 publication Critical patent/DK0790245T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97101597T 1996-02-15 1997-02-03 Substituerede thiophenylalkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf DK0790245T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19605610A DE19605610A1 (de) 1996-02-15 1996-02-15 Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
DK0790245T3 true DK0790245T3 (da) 2001-09-03

Family

ID=7785491

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97101597T DK0790245T3 (da) 1996-02-15 1997-02-03 Substituerede thiophenylalkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf

Country Status (29)

Country Link
US (1) US5756535A (no)
EP (1) EP0790245B1 (no)
JP (1) JP4402747B2 (no)
KR (1) KR970061887A (no)
AR (1) AR005812A1 (no)
AT (1) ATE202096T1 (no)
AU (1) AU706554B2 (no)
BR (1) BR9700990A (no)
CA (1) CA2197628C (no)
CZ (1) CZ45597A3 (no)
DE (2) DE19605610A1 (no)
DK (1) DK0790245T3 (no)
ES (1) ES2158383T3 (no)
GR (1) GR3036122T3 (no)
HR (1) HRP970081B1 (no)
HU (1) HUP9700437A3 (no)
ID (1) ID15889A (no)
IL (1) IL120214A (no)
MX (1) MX9701163A (no)
NO (1) NO315424B1 (no)
NZ (1) NZ314230A (no)
PL (1) PL318412A1 (no)
PT (1) PT790245E (no)
RU (1) RU2193033C2 (no)
SI (1) SI0790245T1 (no)
SK (1) SK282440B6 (no)
TR (1) TR199700109A2 (no)
TW (1) TW445261B (no)
ZA (1) ZA971260B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19634229A1 (de) * 1996-08-23 1998-02-26 Basf Ag Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
EP1180029A4 (en) 1999-04-23 2002-10-02 Bristol Myers Squibb Co BICYCLIC ACYL IHIBITORING SODIUM / PROTON EXCHANGER AND RELATED PROCEDURE.
IL161308A0 (en) 2001-10-19 2004-09-27 Toyama Chemical Co Ltd Alkyl ether derivatives or their salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4402057A1 (de) * 1994-01-25 1995-08-03 Hoechst Ag Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
AU706554B2 (en) 1999-06-17
GR3036122T3 (en) 2001-09-28
HU9700437D0 (en) 1997-04-28
HRP970081B1 (en) 2003-04-30
AU1265997A (en) 1997-08-21
EP0790245A1 (de) 1997-08-20
RU2193033C2 (ru) 2002-11-20
HRP970081A2 (en) 1998-04-30
TR199700109A2 (tr) 1997-09-21
US5756535A (en) 1998-05-26
SK21397A3 (en) 1997-09-10
AR005812A1 (es) 1999-07-14
SK282440B6 (sk) 2002-02-05
HUP9700437A3 (en) 2000-03-28
DE19605610A1 (de) 1997-08-21
TW445261B (en) 2001-07-11
NO970697D0 (no) 1997-02-14
BR9700990A (pt) 1998-09-01
CZ45597A3 (en) 1997-09-17
SI0790245T1 (en) 2001-08-31
HUP9700437A2 (hu) 1998-08-28
JP4402747B2 (ja) 2010-01-20
DE59703746D1 (de) 2001-07-19
PT790245E (pt) 2001-10-30
ZA971260B (en) 1997-08-15
IL120214A0 (en) 1997-06-10
ES2158383T3 (es) 2001-09-01
CA2197628A1 (en) 1997-08-16
IL120214A (en) 2000-08-31
PL318412A1 (en) 1997-08-18
KR970061887A (ko) 1997-09-12
MX9701163A (es) 1997-08-30
EP0790245B1 (de) 2001-06-13
ATE202096T1 (de) 2001-06-15
JPH09249660A (ja) 1997-09-22
CA2197628C (en) 2006-05-16
NZ314230A (en) 1997-12-19
NO315424B1 (no) 2003-09-01
NO970697L (no) 1997-08-18
ID15889A (id) 1997-08-14

Similar Documents

Publication Publication Date Title
DK0825178T3 (da) Phenylsubstituerede alkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
NO964639L (no) Substituerte sulfonimidamider, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO980273L (no) Femleddede heterocykluser med bifenylsulfonylsubstitusjon fremgangsmÕte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO960364L (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO972433D0 (no) Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO963108L (no) Substituerte kanelsyreguanidider, fremgangsmåte for fremstilling, anvendelse som medikament eller diagnostikum som inneholder disse
DK539087A (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK303688A (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK0790245T3 (da) Substituerede thiophenylalkenylcarboxylsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
DK393788A (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK0754680T3 (da) 4-Fluoralkyl-substituerede benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
DK401988A (da) 11-substituerede 5-aryl-5h,11h-pyrrolo(2,1-c)-(1,4)benzoxazepiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO972434L (no) Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO973486L (no) Substituerte indanylidinacetylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikamenter eller diagnostikum og medikamenter inneholdende forbindelsene
DE3774359D1 (de) 3-(1h-tetrazol-5-yl)oxanilsaeure, salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
NO881775L (no) Kondenserte heteroalkylen-kinolinaminer, en fremgangsmaateog mellomprodukter for deres fremstilling samt anvendelseav forbindelsene som medikamenter.
NO964812D0 (no) Sulfonylamino-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO964905D0 (no) Substituerte benzendikarboksylsyre-diguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO980564L (no) Sulfonamid-substituerte forbindelser, fremgangsmÕte for fremstilling, anvendelse som medikament eller diagnostikum samt oppnÕdd medikament er beskrevet
DK225189A (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO972406D0 (no) Bis-orto-substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO970963D0 (no) Ortosubstituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
DK0729954T3 (da) Substituerede thiophenylsulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf
DK321387D0 (da) Cytorhodin s-derivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO970798L (no) Ortosubstituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen